Prescribing safe supply: ethical considerations for clinicians
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol
- Treatment of opioid use disorder in primary care
- Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data
- Combating escalating harms associated with pharmaceutical opioid use in Australia: the POPPY II study protocol
- Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
- Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation
- Public health responses to the opioid crisis in North America
- Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study
- Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study
- Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study